ClinVar Miner

Submissions for variant NM_000435.3(NOTCH3):c.580T>A (p.Cys194Ser)

dbSNP: rs1568361818
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics Inc RCV000711008 SCV000841324 pathogenic not provided 2023-06-28 criteria provided, single submitter clinical testing This variant has been identified in at least one individual with clinical features associated with CADASIL. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). This variant alters a critical location within the protein, and is expected to severely affect function and cause disease. Greater than 90% of NOTCH3 pathogenic variants associated with CADASIL involve the gain or loss of a cysteine residue within the epidermal growth factor (EGF)-like repeat domain (PMID: 32457593, 20301673).
Mayo Clinic Laboratories, Mayo Clinic RCV000711008 SCV004225183 pathogenic not provided 2022-08-29 criteria provided, single submitter clinical testing PP3, PM1, PM2, PS1, PS4_moderate
Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals RCV001175252 SCV001338834 pathogenic Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 2020-02-14 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.